These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15801540)

  • 1. Use of a cocktail of probe substrates for drug-metabolizing enzymes for the assessment of the metabolic capacity of hepatocyte preparations.
    Floby E; Briem S; Terelius Y; Sohlenius-Sternbeck AK
    Xenobiotica; 2004; 34(11-12):949-59. PubMed ID: 15801540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5'-Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography-Tandem Mass Spectrometry.
    Lee B; Ji HK; Lee T; Liu KH
    Drug Metab Dispos; 2015 Jul; 43(7):1137-46. PubMed ID: 25904760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sensitive and specific CYP cocktail assay for the simultaneous assessment of human cytochrome P450 activities in primary cultures of human hepatocytes using LC-MS/MS.
    Pillai VC; Strom SC; Caritis SN; Venkataramanan R
    J Pharm Biomed Anal; 2013 Feb; 74():126-32. PubMed ID: 23245243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry.
    Dierks EA; Stams KR; Lim HK; Cornelius G; Zhang H; Ball SE
    Drug Metab Dispos; 2001 Jan; 29(1):23-9. PubMed ID: 11124225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An automated, high-throughput, 384 well Cytochrome P450 cocktail IC50 assay using a rapid resolution LC-MS/MS end-point.
    Youdim KA; Lyons R; Payne L; Jones BC; Saunders K
    J Pharm Biomed Anal; 2008 Sep; 48(1):92-9. PubMed ID: 18584988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry.
    Testino SA; Patonay G
    J Pharm Biomed Anal; 2003 Jan; 30(5):1459-67. PubMed ID: 12467917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of ten cytochrome P450 enzyme activities with 12 probe substrates in human liver microsomes using cocktail incubation and liquid chromatography-tandem mass spectrometry.
    Kim HJ; Lee H; Ji HK; Lee T; Liu KH
    Biopharm Drug Dispos; 2019 Apr; 40(3-4):101-111. PubMed ID: 30730576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro LC-MS cocktail assays to simultaneously determine human cytochrome P450 activities.
    Dixit V; Hariparsad N; Desai P; Unadkat JD
    Biopharm Drug Dispos; 2007 Jul; 28(5):257-62. PubMed ID: 17443647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryopreserved rat, dog and monkey hepatocytes: measurement of drug metabolizing enzymes in suspensions and cultures.
    Hewitt NJ; Utesch D
    Hum Exp Toxicol; 2004 Jun; 23(6):307-16. PubMed ID: 15301157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sensitive and high-throughput LC-MS/MS method for inhibition assay of seven major cytochrome P450s in human liver microsomes using an in vitro cocktail of probe substrates.
    Liu LY; Han YL; Zhu JH; Yu Q; Yang QJ; Lu J; Guo C
    Biomed Chromatogr; 2015 Mar; 29(3):437-44. PubMed ID: 25098274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential.
    Li AP; Lu C; Brent JA; Pham C; Fackett A; Ruegg CE; Silber PM
    Chem Biol Interact; 1999 Jun; 121(1):17-35. PubMed ID: 10418968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of HμREL Human Coculture System for Prediction of Intrinsic Clearance and Metabolite Formation for Slowly Metabolized Compounds.
    Hultman Ia; Vedin C; Abrahamsson A; Winiwarter S; Darnell M
    Mol Pharm; 2016 Aug; 13(8):2796-807. PubMed ID: 27377099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid chromatography/tandem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping studies in rats.
    Zhang S; Song N; Li Q; Fan H; Liu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(1):78-89. PubMed ID: 18614408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cytochrome P450 (1A2, 2B6, 2C9 and 3A4) induction in cryopreserved human hepatocytes cultured in 48-well plates using the cocktail strategy.
    Gerin B; Dell'Aiera S; Richert L; Smith S; Chanteux H
    Xenobiotica; 2013 Apr; 43(4):320-35. PubMed ID: 23153057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the impact of cantharidin on rat CYP enzymes by using a cocktail of probe drugs.
    Zhou CJ; Qiao LM; Zhao LH; Li ZY
    Fitoterapia; 2015 Dec; 107():49-53. PubMed ID: 26498206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cocktail probe approach to evaluate the effect of hormones on the expression and activity of CYP enzymes in human hepatocytes with conditions simulating late stage of pregnancy.
    Alshabi A; Shaik IH; Zhao Y; Pillai VC; Caritis S; Venkataramanan R
    Eur J Clin Pharmacol; 2023 Jun; 79(6):815-827. PubMed ID: 37060457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2.
    Rhodes SP; Otten JN; Hingorani GP; Hartley DP; Franklin RB
    J Pharmacol Toxicol Methods; 2011; 63(3):223-6. PubMed ID: 21111054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Simultaneous determination of the inhibitory potency of compounds on the activity of five cytochrome P-450 enzymes using a cocktail probe substrates method].
    Gao ZW; Shi XJ; Yu C; Li SJ; Zhong MK
    Yao Xue Xue Bao; 2007 Jun; 42(6):589-94. PubMed ID: 17702393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive assay for nine major cytochrome P450 enzymes activities with 16 probe reactions on human liver microsomes by a single LC/MS/MS run to support reliable in vitro inhibitory drug-drug interaction evaluation.
    Peng Y; Wu H; Zhang X; Zhang F; Qi H; Zhong Y; Wang Y; Sang H; Wang G; Sun J
    Xenobiotica; 2015; 45(11):961-77. PubMed ID: 26007223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictions of cytochrome P450-mediated drug-drug interactions using cryopreserved human hepatocytes: comparison of plasma and protein-free media incubation conditions.
    Mao J; Mohutsky MA; Harrelson JP; Wrighton SA; Hall SD
    Drug Metab Dispos; 2012 Apr; 40(4):706-16. PubMed ID: 22228749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.